Cell Biology

D. Hockenbery, G. Nunez, Curt Milliman, R.D. Schreiber, S.J. Korsmeyer, "Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death," Nature, 348:334-36, 1990. David Hockenbery (Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis): "Bcl-2 is the oncogene located at the breakpoint of the chromosomal translocation t(14;18) found in follicular lymphomas. This paper demonstrated two unique features of the Bcl-2 oncogene. The first is its cel

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

D. Hockenbery, G. Nunez, Curt Milliman, R.D. Schreiber, S.J. Korsmeyer, "Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death," Nature, 348:334-36, 1990.

David Hockenbery (Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis): "Bcl-2 is the oncogene located at the breakpoint of the chromosomal translocation t(14;18) found in follicular lymphomas. This paper demonstrated two unique features of the Bcl-2 oncogene. The first is its cellular role as a survival factor against cell death induced by growth factor deprivation, a model for programmed cell death or apoptosis.

Subsequent work has shown that Bcl-2 protects against a wide variety of apoptosis-inducing agents, including radiation. This is the first example of an oncogene regulating cell survival rather than proliferation.

"The second novel feature of the Bcl-2 oncogene is its subcellular localization, identified in this paper as the inner mitochondrial membrane. Although alterations in mitochondrial function have long been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies